Bone Biopsy Market to grow at a CAGR of 5.49% during 2025 to 2035; Driven by Rising Demand for Bone Disease Diagnosis and Increasing Adoption of Advanced Biopsy Techniques

Bone Biopsy Market Highlights

The global bone biopsy market size was valued at USD 720.0 Million in 2024. The market is projected to grow from USD 759.53 Million in 2025 to USD 1296.15 Million by 2035, registering a CAGR of 5.49% during the forecast period 2025–2035. A bone biopsy is a procedure in which a small bone sample is removed from the outer layers of bone for examination, unlike a bone marrow biopsy, which involves the innermost part of the bone. The bone biopsy sample retains the architecture of bone when seen using a histopathological examination slide. The growth of global bone biopsy is driven by the factors such as the increasing prevalence of bone cancers and the growing demand for minimally invasive procedures. However, stringent regulatory policies hamper the growth of the global market. On the other hand, improving healthcare infrastructure across emerging countries is expected to create lucrative growth opportunities for players operating in the global market of bone biopsy.

Segment Analysis

The global bone biopsy market is segmented into type, guided, end-user and region. The type segment is further segmented into needle biopsy and open biopsy. The guided segment is categorized into MRI-guided and CT-guided. The end user segment is further bifurcated into hospitals & clinics, surgical centers, and others.

Regional Analysis

The global bone biopsy market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World.

North America accounted for the largest share of the global market. This is attributed to the increasing prevalence of bone disorders such as bone cancer, osteoporosis osteomyelitis, and others. According to the American Cancer Society, an estimated 3,910 new cases of primary cancer of the bones and joints are expected to be diagnosed in the US, with about 2,100 deaths reported as a result of the disease in 2022. Moreover, the presence of favorable reimbursement policies, well-developed healthcare infrastructure, and rapid adoption of advanced medical technologies in the region is further positively contributing to the regional market growth during the forecast period.

Asia-Pacific is anticipated to register the highest growth rate over the forecast period. This is due to the factors such as improving healthcare infrastructure, government initiatives, and the increasing patient population suffering from bone cancer, bone Infection, osteoporosis, chronic kidney disease, and other bone disorders. For instance, according to the International Osteoporosis Foundation, by 2050, it is anticipated that Asia would account for over 50% of all osteoporotic hip fractures worldwide. Hence, the rise in bone disorders such as osteoporosis and bone cancer are anticipated to drive the market growth in the region as bone biopsy is used to confirm the diagnosis of a bone disorder, investigate an abnormality, determine the cause of pain or infection, and distinguish bone tumor from other conditions.

Key Findings of the Study

• Technological advancements are enhancing the precision and efficiency of bone biopsy procedures.


• The rising incidence of bone disorders is propelling demand for diagnostic solutions in North America, the largest market.


• The focus on personalized medicine is fostering innovation in the research segment, which is the fastest-growing area.


• Key market drivers include the increasing investment in healthcare infrastructure and growing awareness of bone health.